Mereo is an innovative leader in the #biopharma sector focusing on developing #orphandrugs and #rarediseasetherapies for #rarediseases.

Biotechnology

Mereo BioPharma

Mereo BioPharma's headquarters in New York, NY, United States

Denise Scots-Knight

John Lewicki

Charles S.

Bal Lally CIPD

John Richard

Christine Fox

Anders Ekblom

Pierre Jacquet

Michael Wyzga

Peter Fellner

Jeremy Bender

Anne Hyland

Abdul Mullick

Brian Schwartz

Deepa Pakianathan

The Leadership Team at Mereo BioPharma drives the strategic vision and operational excellence of the company, focusing on advancing innovative therapies for rare diseases and orphan drugs. Comprising key executives like the CEO, CFO, and Chief Scientific Officer, the team collaborates to ensure effective resource allocation, steer clinical development, enhance patient access strategies, and foster business growth in the biopharma sector.

Leadership Team

The Clinical Development Team at Mereo BioPharma is responsible for designing, implementing, and overseeing clinical trials to develop orphan drugs and rare disease therapies. This team ensures the safety and efficacy of new treatments by managing all phases of clinical research, regulatory compliance, and safety assessments.

Clinical Development Team

The Legal and Compliance Team at Mereo BioPharma ensures adherence to regulatory standards, oversees legal affairs, manages intellectual property, and supports business development initiatives, thereby safeguarding the company's interests while advancing its mission to develop therapies for rare diseases.

Legal and Compliance Team

Mereo BioPharma

Org chart

Board & advisors

Teams

Leadership Team

Clinical Development Team

Legal and Compliance Team

Offices

Similar companies